Effects of bolus injection of 20 ml of saline with arm elevation on the onset time of vecuronium administered via a peripheral vei
Not Applicable
Completed
- Conditions
- Patients undergoing elective surgery
- Registration Number
- JPRN-jRCT1090220119
- Lead Sponsor
- Department of Anesthesiology, Faculty of Medicine, Fukuoka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Patients with American Society of Anaesthesiologists physical status I?II, and patients who were within 30% of their ideal body weight.
Exclusion Criteria
Patients with hepatic, renal or neuromuscular disease, and patients who were taking any medications that might interfere with neuromuscular transmission.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain vecuronium's onset time reduction with saline bolus and arm elevation?
How does saline bolus with arm elevation compare to standard vecuronium administration in peripheral vein neuromuscular blockade?
Are there specific biomarkers that predict faster vecuronium onset when using saline bolus and arm elevation techniques?
What adverse events are associated with saline bolus and arm elevation during vecuronium administration via peripheral veins?
What related neuromuscular blocking agents or combination approaches show similar onset time improvements in peripheral vein administration?